Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
NUVB Nuvation Bio Inc
- Stocks
- Healthcare
- NYSE: NUVB
Price (delayed)
$2.45
Market cap
$833.64M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.2
Enterprise value
$797.08M
Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio's proprietary portfolio includes six novel and
Highlights
The gross profit has soared by 125% from the previous quarter
The company's gross margin has surged by 61% QoQ
The company's quick ratio has shrunk by 77% YoY
NUVB's equity is down by 29% year-on-year and by 10% since the previous quarter
Key stats
What are the main financial stats of NUVB
Market
Valuations
Earnings
Shares outstanding
340.26M
Market cap
$833.64M
Enterprise value
$797.08M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.98
Price to sales (P/S)
75.71
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
72.75
Revenue
$10.96M
Gross profit
$1.79M
Operating income
-$631.43M
Net income
-$606.38M
EBIT
-$605.99M
EBITDA
-$605.02M
Free cash flow
-$157.55M
Per share
Balance sheet
Liquidity
EPS
-$2.2
EPS diluted
-$2.2
Free cash flow per share
-$0.47
Book value per share
$1.24
Revenue per share
$0.03
TBVPS
$1.44
Total assets
$492.49M
Total liabilities
$73.03M
Debt
$11.41M
Equity
$419.46M
Working capital
$422.8M
Debt to equity
0.03
Current ratio
9.01
Quick ratio
8.76
Net debt/EBITDA
0.06
Margins
Efficiency
Dividend
EBITDA margin
-5,521.8%
Gross margin
16.3%
Net margin
-5,534.2%
Operating margin
-5,762.8%
Return on assets
-110.3%
Return on equity
-147.6%
Return on invested capital
-130.2%
Return on capital employed
-137.8%
Return on sales
-5,530.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NUVB stock price
How has the Nuvation Bio stock price performed over time
Intraday
0%
1 week
11.36%
1 month
-0.41%
1 year
-6.13%
YTD
-7.89%
QTD
39.2%
Financial performance
How have Nuvation Bio's revenue and profit performed over time
Revenue
$10.96M
Gross profit
$1.79M
Operating income
-$631.43M
Net income
-$606.38M
Gross margin
16.3%
Net margin
-5,534.2%
The gross profit has soared by 125% from the previous quarter
The company's gross margin has surged by 61% QoQ
Nuvation Bio's revenue has increased by 39% from the previous quarter
Nuvation Bio's net margin has increased by 23% QoQ
Price vs fundamentals
How does NUVB's price correlate with its fundamentals
Growth
What is Nuvation Bio's growth rate over time
Valuation
What is Nuvation Bio stock price valuation
P/E
N/A
P/B
1.98
P/S
75.71
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
72.75
NUVB's EPS is down by 4.3% QoQ
The stock's price to book (P/B) is 45% less than its 5-year quarterly average of 3.6 but 10% more than its last 4 quarters average of 1.8
NUVB's equity is down by 29% year-on-year and by 10% since the previous quarter
The price to sales (P/S) is 68% less than the last 4 quarters average of 233.2
Nuvation Bio's revenue has increased by 39% from the previous quarter
Efficiency
How efficient is Nuvation Bio business performance
NUVB's ROS is up by 23% QoQ
NUVB's ROE is down by 18% from the previous quarter
The return on invested capital has declined by 16% since the previous quarter
NUVB's return on assets is down by 13% since the previous quarter
Dividends
What is NUVB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NUVB.
Financial health
How did Nuvation Bio financials performed over time
The current ratio has shrunk by 77% YoY
The company's quick ratio has shrunk by 77% YoY
Nuvation Bio's debt is 97% lower than its equity
The debt to equity has soared by 200% YoY and by 50% QoQ
NUVB's equity is down by 29% year-on-year and by 10% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.